LBF20207PG10: Difference between revisions
No edit summary |
No edit summary |
||
| (14 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
{{Metabolite | {{Metabolite | ||
|LipidBank=XPR1728 | |LipidBank=XPR1728 | ||
|LipidMaps=LMFA03010047 | |LipidMaps=LMFA03010047 | ||
|SysName=9- | |SysName=9-Oxo-15R-hydroxy-prostsa- (cis-10,trans-13) -dien-1-oic acid | ||
|Common Name=&&15-epi Prostaglandin | |Common Name=&&15-epi Prostaglandin A_1&&9-Oxo-15R-hydroxy-prostsa- (10Z,13E) -dien-1-oic acid&& | ||
|Source=15-epi PGA1 is produced by gorgonia soft corals.[[Reference:Krakoff_LR:Vlachakis_N:Mendlowitz_M:Stricker_J:,Clin. Sci. Mol. Med. Suppl.,1975,2,311s|{{RelationTable/GetFirstAuthor|Reference:Krakoff_LR:Vlachakis_N:Mendlowitz_M:Stricker_J:,Clin. Sci. Mol. Med. Suppl.,1975,2,311s}}]] | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Latest revision as of 08:21, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1728 |
| LipidMaps | LMFA03010047 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG10 |
| 15-epi Prostaglandin A1 | |
|---|---|
| |
| Structural Information | |
| 9-Oxo-15R-hydroxy-prostsa- (cis-10,trans-13) -dien-1-oic acid | |
| |
| Formula | C20H32O4 |
| Exact Mass | 336.23005951199997 |
| Average Mass | 336.46567999999996 |
| SMILES | CCCCCC(O)C=CC(C=1)C(CCCCCCC(O)=O)C(=O)C1 |
| Physicochemical Information | |
| 15-epi PGA1 is produced by gorgonia soft corals. Krakoff_LR et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
